Pharmacological action

 Barboval - sedative and hypnotic.

This drug has antispasmodic, hypotensive and sedative effect. 1 ml Barboval contains 18 mg of ethyl alpha bromizovalerianovoy acid, 80 mg and 17 mg validola phenobarbital. Application Barboval reduces bloating and relax the smooth muscles and slow down the motility of the stomach and intestines, due to the action of validol. Also, this component of calming effect on the central nervous system, has a mild vasodilator and antispasmodic properties. These same properties have, to varying degrees, and other active ingredients Barboval.

Phenobarbital quite rapidly absorbed in the stomach, binding to plasma proteins - about 40-60% is excreted in the urine in unchanged form (30%). Reapply Barboval Phenobarbital triggers accumulation in the body. Barboval reviews confirm softer and lasting effect of the drug compared to korvalola.

Indications Barboval

According to the instructions, Barboval appointed in the following cases:

  • insomnia, hysteria, irritability accompanying neuroses;
  • sinus tachycardia, hypertension, the first stage, slight attacks of angina pectoris;
  • gastric and intestinal cramps, flatulence.

Dosing Barboval

 Thomas Release Barboval - drops
 The drug is available in the form of a solution to be taken orally. A single dose of an adult, indicated in the instructions for Barbovalu corresponds to 10-15 drops of the drug, the multiplicity of reception - 2-3 times a day. Take Barboval recommended before meals (20-30 minutes), drink a little water or put under the tongue, pre-drip drug on a sugar cube. More precise dosage and duration of treatment is determined by the attending physician.

According to the reviews of Barbovale, use of the drug is more effective if 10-15 days break to resume treatment.

side effects

In rare cases, an overdose can occur Barboval watery eyes, dizziness, nausea and drowsiness. These undesirable effects disappear after drug withdrawal or dose reduction.


According to the instructions, Barboval not administered to children, pregnant and lactating women, as well as individuals with hypersensitivity to the active ingredients of the drug.

Additional Information

Storage Barboval should be carried out in a dark place where the temperature does not exceed 25 0 C. Since the release of the drug is considered to be fit within two years.